In people with long COVID, arterial stiffness in the large vessels looked no different from people who’d recovered cleanly.
The deficit sits one level down - in the smallest vessels, and specifically in how fast they can react.🧵
A new paper from Tübingen measured microvascular reactivity - how quickly a muscle re-oxygenates after its blood supply is cut off for a few minutes and then released. That re-flooding step is called reperfusion. A near-infrared sensor on a forearm muscle tracks how oxygenated the tissue is throughout.
29 patients with symptoms lasting more than 12 months after infection and a real impact on daily life, against 33 people who had the same infection and recovered without trouble. Everyone was infected in 2020–2021.
Reperfusion was slower in the patients (1.67 vs 2.23 %/s). Meanwhile large-artery stiffness, the ankle-brachial index, and resting values didn’t differ. So the deficit isn’t in the large arteries and isn’t about the resting state - it’s in the small vessels’ ability to dilate on demand.
The patients are less fit, so they perfuse worse. The authors expected that - the patients did have lower aerobic fitness (VO₂max). So they adjusted the reperfusion difference to subtract the effect of fitness. It survived. And it didn’t track with how much physical activity people reported.
Fitness is subtracted statistically, not physically, and activity was captured by a questionnaire with three-month recall. So the honest version - fitness doesn’t fully explain the deficit - not that it’s been proven unrelated to conditioning.
The patient group carried more cardiovascular risk and medication - a quarter were on anticoagulants, versus 3%. The authors admit they can’t tell whether that’s a consequence of COVID or something that predated it. Part of the measured gap could ride on that imbalance.
What might blunt that on-demand dilation?
Lower availability of nitric oxide (vasodilator released by the vessel lining), autoantibodies against vascular receptors, microclots, smoldering inflammation. None of these mechanisms were measured here
It slots into a growing pile of data on endothelial and microvascular dysfunction after COVID. And it fills in the exercise-intolerance picture. Other work has shown reduced oxygen extraction at the periphery and damaged mitochondria in muscle. This adds a middle link - the delivery of oxygen through the smallest vessels.
It’s a case-control study at a single time point. The sample is small and mildly underpowered.
One detail actually works in the finding’s favor. The controls had also been infected and could carry hidden vascular changes. That would tend to wash the difference out - so the real effect may be larger, not smaller.
In post-COVID exercise intolerance there’s an objective peripheral vascular limit you can measure right at the muscle. For rehab, the brake may be in how oxygen reaches the muscle in the first place.
Thiel at al., Impaired microvascular reactivity in post-COVID-19 syndrome is independent of cardiorespiratory fitness. journals.physiology.org/doi/full/10.11…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
New study out of Amsterdam UMC asks a question most Long COVID imaging papers don’t tackle at once - does inflammation in the brain actually track with how well different brain regions talk to each other? 45 people, roughly 27 months post-infection!🧵
TSPO PET is a scan that lights up wherever immune cells in the brain (microglia) are activated - basically a map of where inflammation is happening. This version is fully quantitative, with blood sampling during the scan, not a shortcut estimate.
The second scan, resting-state fMRI, measures which brain regions sync up while someone just lies there doing nothing.
Severe COVID at least temporarily (years) weakens the part of the immune system that keeps dormant and opportunistic pathogens in check. 3.6 mio dataset from Chile shows this on a textbook example - tuberculosis🧵
People hospitalized with COVID had more than an eightfold higher risk of TB flaring up over the following year.
That watch has a name - cell-mediated immunity. Dormant TB is kept walled off in a tiny lesion (granuloma) by a team of T cells, IFN-γ (inflammatory signaling molecule), macrophages.
COVID ages the brain. But we keep hitting the same wall - how do you prove it when the brain changes over years and we only have data spanning months?
A new study tried to get around that wall through a completely different door. Genetics.🧵
The logic is clever. Everyone gets their genes shuffled at random at conception - and some of that shuffle makes people more prone to severe COVID.
Nobody chose that susceptibility. It was dealt randomly, for life, long before any illness. That’s what makes it almost an experiment - one that isn’t tangled up by lifestyle or by the usual which came first problem.
If you wear a Fitbit or a smartwatch, you may have noticed your HRV drop and your resting heart rate climb after COVID. Data from 1,475 people in the RECOVER cohort now confirm that pattern objectively - from passively collected sensor data🧵
The study took passive wearable data from 1,475 people a median of ~21 months (!) after infection and matched it against a symptom questionnaire. The differences between groups are small but statistically solid.
What the wearable actually measures?
HRV = the variation in the gaps between beats - higher usually means a more flexible autonomic nervous system.
Resting heart rate = how fast your heart beats at rest. Both track with cardiac health at the population level.
Researchers built a mouse with a human immune system to finally watch how human defenses fight COVID. They expected the virus to get wiped out. Instead, the human immune cells helped it spread from the lungs into other organs and muffled the body's own early alarm system🧵
Older COVID mouse models had two problems. The virus's entry lock - the ACE2 - was cranked up to artificial levels, so the mice died of things we don't see in people. And their human T cells developed badly and attacked the mouse's own body.
This mouse fixes both. Human ACE2 sits at natural levels, in the same tissues as in people. And the human T cells mature in a transplanted human thymus so they behave normally. The key study trick - some mice have a human immune system with T cells, some without. That lets you measure exactly what the T cells do.
New study in Journal of Sleep Research links long COVID to a higher burden of prodromal Parkinson's like features. 11,261 people, 16 countries.
The headline is weaker than it looks - but there is the one finding in this paper that should genuinely scare you, and almost nobody is quoting it 🧵
The main finding is mostly circular. The prodromal PD score is built from cognitive impairment, fatigue, depression, dysautonomia, anosmia, constipation. Those are long COVID. They renamed the long COVID symptom cluster prodromal PD and found long COVID predicts it.
Cognitive impairment carries OR 7.0 in their model. That's not a Parkinson's. That's brain fog wearing a different name tag.
Drop the six overlapping items and the effect barely moves aOR 1.73 - 1.66 because the overlap runs deeper than six items.